| |
| | Redux To Be Voluntarily Withdrawn; Pondimin Also To Be Withdrawn, 9/15/97 Business Newswire |
 | | Interneuron has been named, together with other pharmaceutical companies, as a defendant in a number of legal actions involving the use of Redux and other weight loss drugs. |
 | | Interneuron Pharmaceuticals is a diversified biopharmaceutical company engaged in the development and commercialization of a portfolio of products and product candidates primarily for neurological and behavioral disorders. |
 | | Interneuron is also developing products and technologies, generally outside the central nervous system field, through four subsidiaries: Intercardia, Inc. focused on cardiovascular disease, Progenitor, Inc. focused on developmental genomics, Transcell Technologies, Inc. focused on carbohydrate-based drug discovery, and InterNutria, Inc. focused on dietary supplement products. |
| www.antidepressantsfacts.com /redux-3.htm (1059 words) |
|